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Chloroaluminum phthalocyanine (ClAlPc) is a promising sensitizer molecule for photodynamic therapy,
but its hydrophobicity makes it difﬁcult to formulate. In this study, we have efﬁciently encapsulated ClA-
lPc into gelled soybean oil particles dispersed in water. 12-Hydroxystearic acid (HSA) and polyethylene-
imine (PEI) were the gelling and stabilizing agents, respectively. The preparation process involved hot
emulsiﬁcation above the gelation temperature (Tgel), followed by cooling to room temperature, which
gave a colloidal dispersion of gelled particles of oil in aqueous medium. The gelled particles containing
ClAlPc had a medium diameter of 280 nm, homogeneous size distribution (polydispersity index 0.3)
and large positive zeta potential (about +50 mV) and showed a spherical morphology. The gelled oil par-
ticle formulations exhibited good physical stability over a 6-month period. ClAlPc interfered with the HSA
self-assembly only slightly, and decreased the gelation temperature to a small extent; however it did not
affect gelation process of the oil droplets. The amounts of PEI and HSA employed during the preparation
allowed us to control particle size and the dispersion stability, a phenomenon that results from complex
electrostatic interactions between the positively charged PEI and the negatively charged HSA ﬁbers pres-
ent on the gelled particles surface. In summary, by using the right ClAlPc, HSA, and PEI proportions, we
prepared very stable dispersions of gelled soybean oil particles with excellent ClAlPc encapsulation efﬁ-
ciency. The obtained colloidal formulation of gelled oil particles loaded with ClAlPc shall be very useful
for photodynamic therapy protocols.
Crown Copyright  2013 Published by Elsevier Inc. All rights reserved.1. Introduction
Strategies from particulate colloidal dispersion have led to sig-
niﬁcant advances in drug delivery system research applied to the
encapsulation of hydrophobic molecules [1,2]. Such approaches
have become essential, because about 40% of the new molecules
identiﬁed by pharmaceutical companies are practically insoluble
in water. The lipophilic character of a molecule limits its bioavail-
ability and absorption, thus preventing the pharmacological and
pre-clinical evaluations of hydrophobic drugs [1–4]. In this context,
several drug delivery systems based on lipid core have been devel-
oped to enhance the low solubility and bioavailability of lipophilic
molecules [5,6].013 Published by Elsevier Inc. All r
otobiologia e Fotomedicina/
antes 3900, 14040-901, Vila
6024838.Gelled particles have emerged as a successful system for drug
delivery. These gelled particles comprise hydrogels and organogels,
and they combine the unique properties of a gel with those of col-
loidal particles (e.g., very small size) [7–9]. Organogels (Ogg) are
semisolid materials in which an organic solvent (e.g., vegetable
oil) is entrapped in a three-dimensional ﬁbrous network formed
by self-aggregation of the organic gelator. Such gels are normally
obtained by directly dissolving the gelator in oil at high tempera-
ture, followed by cooling of the solution to a temperature below
the gelation transition temperature (Tgel). At Tgel, the oil ﬂow is
no longer observed over long periods [10,11]. Ogg are interesting
drug delivery systems for different administration routes [12,13],
and their potential as hydrophobic reservoirs has been demon-
strated [14–17]. Recently, a new approach based on an original
family of lipophilic drug carriers consisting of organogel particles
has been successfully developed as a nanocarrier system applied
to dye molecules [7,18]. The stabilizing and gelling agents are the
main components in the process of Ogg particles production. Theseights reserved.
Fig. 1. Chemical structure of chloroaluminum phthalocyanine (ClAlPc).
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ters, such as average diameter and zeta potential, as well as the
colloidal dispersion physical stability. Both Ogg particle production
and stability depend on the interfacial interactions between the
particle and stabilizing agent, reinforced by a possible complexa-
tion between the organogelator and stabilizing agent. This com-
plexation occurs mainly through electrostatic interactions with
the organic gelator ﬁbers present at the surface of the Ogg particles
[7,18].
Phthalocyanines are photosensitizer drugs (PS) belonging to the
second-generation of sensitizer molecules used in photodynamic
therapy (PDT). They replace the less effective ﬁrst-generation PS
such as hematoporphyrins [6]. Metallophthalocyanines result from
incorporation of diamagnetic metals like zinc, aluminum, or silicon
into the phthalocyanine macrocycle. Phthalocyanines containing
Al or Zn are considered to be the most photoactive compounds, be-
cause their large triplet state quantum yields and long triplet life-
times give the highest singlet oxygen (1O2) production [6,19].
Cytotoxic species burst, such as 1O2, occurs when visible light of
appropriate wavelength (normally the maximum absorption
wavelength of the PS) interacts with a PS in the presence of oxygen,
leading to cell death and tumor destruction [20,21]. Chloroalumi-
num phthalocyanine (ClAlPc) (Fig. 1) is a promising PS because of
its strong absorption in the visible spectral region (670–680 nm),
exceptional thermal and chemical stability, and excellent photo-
physical and photochemical properties [19,22–24]. Despite all
the potential advantages of ClAlPc for PDT, this metallophthalocy-
anine is practically insoluble in water, which prevents its direct
application in biological ﬂuids. In addition, hydrophobic phthalo-
cyanines dimerize or aggregate, in aqueous medium, which inacti-
vates the PS and diminishes the production of singlet oxygen
[24,25] or other reactive oxygen species.Table 1
Main components of the ClAlPc Ogg particle formulations and experimental results from
Formulations PEI (%)a HSA (%)b Mean size (nm)c
F1 0.075 6 349.8 (±8.5)
F2 0.15 6 310.4 (±14.1)
F3 0.30 6 282.7 (±3.0)d
F4 0.625 6 283.8 (±5.9)d
F5 0.30 3 Unstable formulation (creaming and ph
F6 0.30 4 323.6 (±9.8)
F7 0.30 8 249.4 (±7.8)d
F8 0.30 15 Unstable formulation (compact aggrega
a % w/v.
b % w/w, based on oil phase weight.
c Mean ± SEM (n = 3).
d p < 0.05 Compared to F1, F2, and F6 formulations.
e,f p < 0.05 Compared to F3, F4, F6, and F7 formulations.
g p < 0.05 Compared to F1, F2, F6, and F7 formulations.In this study, we prepared organogel particles containing ClAlPc
(ClAlPc Ogg particles) using soybean oil and a low-molecular-
weight organic gelator, such as 12-hydroxystearic acid (HSA). We
obtained a colloidal suspension of ClAlPc Ogg particles by dispers-
ing the ClAlPc Ogg in an aqueous solution containing the cationic
polymer polyethyleneimine (PEI) as stabilizing agent. We charac-
terized the resulting ClAlPc Ogg particles in terms of the average
diameter, size distribution, zeta potential, encapsulation efﬁciency,
physical stability, and morphology. In addition, we assessed the
thermal behavior of Ogg and ClAlPc Ogg by differential scanning
calorimetry. Therefore, the purpose of this study was to develop
an innovative class of colloidal particles able to encapsulate a
hydrophobic photosensitizer drug for application in PDT.2. Materials and methods
2.1. Materials
Aluminum phthalocyanine chloride (85% pure), branched poly-
ethyleneimine (PEI, Mn = 600 g/mol), soybean oil, and methanol
were purchased from Sigma (Sigma–Aldrich Co., St. Louis, MO,
USA). 12-Hydroxystearic acid (HSA, 99%) was obtained from Alfa
Aesar GmbH (Karlsruhe, Germany). All the other chemicals were
of analytical grade. Ultrapure water was used to prepare the colloi-
dal dispersions.
2.2. Preparation and optimization of ClAlPc Ogg particle formulations
ClAlPc Ogg particles were prepared according to the method de-
scribed by Kirilov et al. [18], with some modiﬁcations. This method
involved two steps: organogel preparation and the subsequent for-
mation of the Ogg particle dispersion.
Firstly, the ClAlPc Ogg was prepared by dissolving the gelling
agent (HSA) and ClAlPc in soybean oil at 75 C for 40 min. After
complete HSA and ClAlPc dissolution in the oil, the mixture was
cooled naturally to room temperature leading to a compact gel
formed. Then, 10 ml of an aqueous solution containing the stabiliz-
ing agent (PEI) was added to the previously obtained gel. This mix-
ture was heated to 75 C (above the gel melting temperature) for
40 min, which gave in an oil layer on top of the aqueous solution.
Next, the hot mixture was dispersed by ultrasound sonication (Vi-
bra Cell, Bioblock Scientiﬁc) for 10 min using a 13-mm probe oper-
ating at a power of 400 W and frequency of 20 Hz. The resulting
colloidal suspension was cooled to room temperature, to give a dis-
persion of ClAlPc Ogg particles. All the formulations were stored at
4 ± 2 C for a period no longer than 6 months.physicochemical characterization.
PdIc f Potential (mV)c ClAlPc loading (%)
0.41 (±0.04)e +65.5 (±1.9)f 10.7 (±0.4)
0.47 (±0.01)e +56.7 (±1.2)f 22.3 (±0.2)
0.34 (±0.03) +49.3 (±1.8) 60.3 (±1.7)g
0.37 (±0.02) +45.7 (±1.8) 63.1 (±2.8)g
ase separation)
0.32 (±0.04) +52.6 (±0.8) 41.6 (±1.3)
0.33 (±0.02) +53.9 (±1.4) 38.4 (±1.7)
te)
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tions of the stabilizing (PEI) and gelling (HSA) agents were varied
from 0.075% to 0.625% (w/v) and 3–15% (w/w), respectively, as
shown in Table 1. Soybean oil and ClAlPc concentrations were ﬁxed
at 5% (w/v) and 0.003% (w/w), respectively. For all the formula-
tions, HSA was considered as an oil additive, so its weight percent-
age was based on the oily phase only. Each colloidal dispersion was
prepared in triplicate.
2.3. Physicochemical characterization of ClAlPc Ogg particles
2.3.1. Particle size and polydispersity index analysis
The mean diameter and polydispersity index (PdI) of the ClAlPc
Ogg particles were determined at 25 C by photon correlation spec-
troscopy (PCS) at a scattering angle of 173 (Zetasizer Nano ZS,
Malvern PCS Instruments, UK). Samples were prepared by diluting
30 ll of gelled nanoparticles with 3 ml of ultrapure water. The re-
ported values are mean ± SEM for three different batches of each
colloidal dispersion.
2.3.2. Zeta potential measurement
The zeta potential (or f potential) of the ClAlPc Ogg particles
was measured by electrophoretic mobility assayed on Zetasizer
Nano ZS (Malvern PCS Instruments, UK). The Smoluchowski model
was used to estimate the f potential from electrophoretic mobility.
The analyses were performed at 25 C, and the samples were
appropriately diluted (1/100) with ultrapuriﬁed water and the
pH measured. The reported values are mean ± SEM for three differ-
ent batches of each colloidal dispersion.
2.4. ClAlPc quantiﬁcation in Ogg particles
2.4.1. Encapsulation efﬁciency (EE) and ClAlPc loading determination
The ClAlPc content in Ogg particles was determined by spectro-
ﬂuorimetry (Fluorolog-3 Spectroﬂuorimeter, Horiba, New Jersey,
USA) using a previously validated analytical method with some
modiﬁcations [26]. Brieﬂy, an aliquot of ClAlPc Ogg particles was
accurately weighed (100 mg) and dissolved in 7.5 ml of methanol.
The resulting mixture was sonicated for 15 min and diluted with
methanol, to give a ﬁnal volume of 10 ml. In addition, the free ClA-
lPc content in the formulations was determined by measuring the
non-incorporated ClAlPc present in the clear ultraﬁltrate obtained
after separation of the aqueous phase by ultraﬁltration/ultracentri-
fugation (Microcon Ultracel YM-100, Millipore, Ireland) at 12857g
for 1 h, at 4 C (Centrifuge 5810 R, Eppendorf, Hamburg, Germany).
Both free and encapsulated ClAlPc were measured by spectroﬂuo-
rimetry at ﬁxed excitation and emission wavelengths of 615 and
674 nm, respectively. The efﬁciency of ClAlPc incorporation into
the Ogg particles was calculated by:
EEð%Þ ¼total ClAlPc contentðlg g1Þ
 free ClAlPc concentrationðlg g1Þ
=total ClAlPc contentðlg g1Þ  100 ð1Þ
ClAlPc loadingð%Þ ¼ photosensitizer concentration in
the formulationðlg g1Þ=
theoretical ClAlPc concentrationðlg g1Þ
 100 ð2Þ2.5. Stability assessment
The effect of storage time on the particle size and f potential of
the ClAlPc Ogg particles was assessed by storing colloidal disper-
sions in sealed glass bottles kept at 4 C and in the dark for sixmonths. The reported values are mean ± SEM for three different
batches of each colloidal dispersion.
2.6. Morphological study
The morphology of the ClAlPc Ogg particles was evaluated by
transmission electron microscopy (TEM) (JEOL JEM-1200EX,
70 kV). To this end, the samples were diluted (30 mg) in 3 ml of
ultrapure water, negatively stained with 1% (w/v) sodium phos-
photungstate solution, and ﬁxed on copper grids.
2.7. Differential scanning calorimetry of organogels
Thermal properties of the organogel without ClAlPc (unloaded
organogel, Ogg) and of the ClAlPc-loaded organogel (ClAlPc Ogg)
were examined in a differential scanning calorimeter (Mettler To-
ledo, Virolay, France). Both organogels were prepared with 3%, 4%,
6%, and 8% (w/w) HSA and for ClAlPc Ogg a ﬁxed amount of the PS
(0.003%, w/v) was added. All the gel samples were melted at 75 C,
and 7–9 mg drops of the sol were placed in hermetically sealed
aluminum pans. An empty aluminum pan was used as reference.
DSC runs were carried out between 5 and 90 C, and the samples
were scanned at a constant rate of 2 C min1 in the heating–cool-
ing cycle. The sol-to-gel transition temperatures (Tgel) were deter-
mined in triplicate for each sample.
2.8. Statistical analysis
All the experiments were performed in triplicate and data are
expressed as the mean value ± SEM. Statistical analysis was per-
formed by One-way ANOVA followed by Tukey’s pairwise compar-
isons using the Prism 3.0 GraphPad Software. The statistical
signiﬁcance was set at p < 0.05.3. Results
3.1. Characterization and optimization of the ClAlPc Ogg particles
3.1.1. Effects of the stabilizing and gelling agents on mean diameter
and size distribution
Firstly, the inﬂuence of the stabilizing agent concentration on
the average size and size distribution of the colloidal formulations
was evaluated while keeping the HSA concentration at 6%. To this
end, we prepared ClAlPc Ogg particles with PEI concentrations
ranging from 0.075% to 0.625% (w/v). Table 1 summarizes the
mean diameter and size distribution results for the ClAlPc Ogg par-
ticles prepared at four PEI concentrations, F1, F2, F3, and F4. Colloi-
dal formulations prepared at PEI concentrations lower than 0.15%
(F1 and F2) had signiﬁcantly different (p < 0.05) mean size and
PdI values from those prepared at larger PEI concentrations (F3
and F4). Both F3 and F4 presented particles with lower mean diam-
eter and narrower size distribution compared with F1 and F2; i.e., a
concentration of at least 0.30% PEI furnished smaller particles and
homogeneous dispersion. It can be seen from the data in Table 1
that increasing PEI percentage provided small particles and slightly
reduced PdI.
Next, we varied the gelling agent (HSA) concentration from 3%
to 15% (w/w in relation to the oil phase total weight) while main-
taining a ﬁxed PEI concentration of 0.30% (w/v) and an oil concen-
tration of 5% (w/v). We obtained unstable dispersions at the lowest
and highest HSA concentrations (3% and 15%, Table 1), which re-
sulted in creaming or compact aggregation after the preparation
process. As Table 1 shows, the particle size decreased for the ClAlPc
Ogg particles prepared with 4%, 6%, or 8% HSA (F6, F3, and F7,
respectively), and this was associated with increasing HSA
Fig. 2. Zeta potential variation of ClAlPc Ogg particle dispersions under the inﬂuence of PEI (left, ﬁxed HSA 6%, w/w) and HSA (right, ﬁxed PEI 0.3%, w/v) concentrations.
Fig. 3. Inﬂuence of PEI concentration on the total content of ClAlPc in the colloidal
dispersions.
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distribution of the ClAlPc Ogg particle formulations, so the PdI of
F3, F6, and F7 did not differ (p > 0.05).
3.1.2. Effects of the stabilizing and gelling agents on zeta potential
All the formulations of ClAlPc Ogg particles had signiﬁcantly po-
sitive surface charge (Table 1). The colloidal dispersions prepared
with 0.075% and 0.15% PEI (F1 and F2) presented higher f potential
values than those formulations with 0.30% and 0.625% PEI (F3 and
F4). Increasing PEI percentage reduced the f potential of ClAlPc Ogg
particles. On the other hand, for the formulations containing 4%
and 8% HSA (F6 and F7) the surface charge of gelled particles did
not vary (p > 0.05) (Fig. 2). The pH values were 6.1, 6.0, 6.8, 6.5,
6.7, 6.8 for F1, F2, F3, F4, F6, and F7 samples, respectively.
3.2. Encapsulation efﬁciency (EE) and ClAlPc loading determination
The EE for ClAlPc into Ogg particles was approximately 100% for
all the formulations, as expected for a lipophilic photosensitizer
drug. On the other hand, The ClAlPc loading varied considerably,
from 10.7% (±0.4) to 63.1% (±2.8). We veriﬁed variation among for-
mulations with ﬁxed HSA concentration and different PEI concen-
trations (F1, F2, F3, and F4), and also between these formulations
and those prepared with different HSA percentages and ﬁxed PEI
concentration (F3, F6, and F7) (p < 0.05) (Table 1).
F1 and F2 formulations prepared with the lowest PEI concentra-
tions (0.075% and 0.15%) had 6-fold lower ClAlPc loading than F3
and F4 formulations. The loading for ClAlPc into F3 and F4 prepara-
tions did not differ (p > 0.05), and these formulations had the high-
est loading rate of all the samples (Table 1). To assess the inﬂuence
of the stabilizing agent (PEI) concentration on ClAlPc loading, we
prepared ClAlPc Ogg particle dispersions with 0.20% and 0.25%
PEI (w/v) and ﬁxed HSA concentration (6%), which gave loading
values of 32.9% and 48.4%, respectively. These ﬁndings conﬁrmed
that the PEI concentration inﬂuences ClAlPc loading into the gelled
colloidal particles, and that the loading rate increased with rising
PEI percentage. The highly positive correlation (r  0.99) among
PEI percentages from 0.075% to 0.30% corroborated the strong cor-
relation between total ClAlPc content and PEI concentration
(Fig. 3). For all the samples, partial loss of ClAlPc Ogg particles ac-
counted for decreased ClAlPc loading, and a coating appeared on
the glass surface of the vessel.
3.3. Assessment of the stability of ClAlPc Ogg particle dispersions
Physical stability of ClAlPc Ogg particles was assessed as a func-
tion of time over six months. To this end, we stored all the colloidal
dispersions obtained from the optimization study at 4 C, in thedark. The mean size and zeta potential were used as stability indi-
ces throughout this evaluation. F1 formulation, with low amount of
PEI and larger size, showed instability signs such as slightly cream-
ing followed by separating the phases after ﬁrst month (Fig. 4). The
size and zeta potential of F2 and F6 formulations changed slightly,
while F7, with the higher proportion of HSA increasing the ﬁbers
interconnection between particles [27], presented signiﬁcantly al-
tered size associated with creaming process after six months. F3
and F4 were the most physically stable formulations, since they
presented minor variation on particle size and zeta potential
(Fig. 4).
3.4. Morphological study
Morphology of ClAlPc Ogg particles was examined by TEM.
Fig. 5 corresponds to the image of F3 formulation. ClAlPc Ogg par-
ticles were spherical and had average diameters of less than
300 nm, corroborating the photon correlation spectroscopy analy-
sis results. Moreover, the bright areas observed on the surface of
the ClAlPc Ogg particles possibly result from zones of high HSA-ﬁ-
ber density. It is worth noting that the dried samples used in the
TEM analyzes could be deformed due to particles and grid interac-
tions (aggregate), and/or oil evaporation from the particle core.
3.5. Differential scanning calorimetry of Ogg and ClAlPc Ogg
The thermal properties of Ogg and ClAlPc Ogg were investigated
in the temperature range of 5–90 C by differential scanning
calorimetry (DSC). Fig. 6 shows the DSC heating and cooling
Fig. 4. Aging inﬂuence on the average diameter and zeta potential of ClAlPc Ogg
particles.
Fig. 5. TEM micrograph of ClAlPc Ogg particles (F3 formulation).
Fig. 6. DSC thermograms of unloaded organogels (Ogg) and organogels containing
ClAlPc (ClAlPc Ogg) prepared with 3%, 4%, 6%, and 8% HSA (w/w).
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During heating, endothermic peaks were observed between 56.0
and 64.1 C for Ogg and 56.2 and 63.3 C for ClAlPc Ogg, for differ-
ent gelling agent (HSA) concentrations. These peaks correspond to
ﬁrst order endothermic transitions typical of the melting process.
The melting characteristics of all the samples (i.e., beginning and
end of melting, peak melting temperature, and enthalpy) increased
with rising HSA concentration. Although the transitions occurred
over a temperature range, we took the peak temperatures as the
melting temperatures (Tm). The melting properties of the materials
prepared with a similar HSA percentage did not differ signiﬁcantly
(p > 0.05).
On cooling, exothermic peaks were observed from 49.8 to
58.6 C for Ogg and from 35.5 to 51.6 C for ClAlPc Ogg prepared
with different HSA concentrations. As can be seen from Fig. 6,
the gelation characteristics of organogels varied according to the
HSA concentration and ClAlPc addition. Thus, the gelation process
of the Ogg and ClAlPc Ogg samples differed signiﬁcantly (p < 0.05).Furthermore, ClAlPc Ogg having low HSA concentrations were
more affected by ClAlPc during formation of the gelled matrix.4. Discussion
Gelled particles have received considerable attention as drug
delivery systems due to mainly their very interesting advantages
such as ease of preparation and administration [8,9]. In this con-
text, we used a new approach to encapsulate the hydrophobic pho-
tosensitizer ClAlPc; i.e. gelled oil particles.
During ClAlPc Ogg particle preparation and optimization at
ﬁxed HSA concentration (6%), increased PEI concentration
(0.075–0.625%) resulted in markedly reduced mean particle size.
This could be explained by increased complexation between the
PEI positive charge and the negative charge of HSA ﬁbers at the
surface of the particle, leading to diminished hydrodynamic diam-
eter of ClAlPc Ogg particles. PEI is a synthetic polymer that is very
soluble in water and has high capacity for acquiring positive
charge. Branched PEI contains primary, secondary, and tertiary
amines, which can all be potentially protonated [28,29]. In addi-
tion, formation of this complex is inﬂuenced by the level of PEI pro-
tonation on the one hand and the ﬂexibility of the polymer chains
on the other hand [28,29]. Accordingly, the particle size analysis
results could also be attributed to the low molecular weight of
the branched PEI used in this work, which contains a high level
of primary amines (42%) [28]. These conditions should result in
maximum protonation of the amino functions with consequent
high positive charge, promoting a strong electrostatic interaction
between PEI and the HSA ﬁbers.
Increased HSA concentration (4–8%) also led to in decreased
ClAlPc Ogg particle diameter. However, at the lowest and highest
HSA percentages, 3% and 15%, respectively, ClAlPc Ogg particles
were unstable. According to Boudier et al. [7], an inadequate
amount of negative charge at low HSA concentration prevents for-
mation of a stable complex with PEI. On the other hand, at high
concentration of HSA, the resulting organogel matrix is denser,
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PEI branched polymer. Also, increased HSA concentration in the
formulations could increase the density of negative charges on
the ClAlPc Ogg particle surface, resulting in better PEI adsorption.
This process would decrease the polymeric corona around the ClA-
lPc Ogg particles, thus reducing the hydrodynamic diameter [7].
The f potential is an important physicochemical parameter of a
colloidal dispersion. The electric charge on the surface of gelled
particles inﬂuences the interaction of the dispersed particles with
a biological target and physical stability of the formulations [30].
All the ClAlPc Ogg particle formulations prepared had positive f po-
tential, and this parameter was mainly inﬂuenced by the PEI con-
centration. However, it is difﬁcult to explain simply its variation
because of the multiple interactions at the interface of the particle,
especially considering the complexation between the HSA ﬁbers
and the PEI.
The encapsulation of a hydrophobic molecule in Ogg particles is
related to the solubility of this molecule in the oily core. In this
study, the encapsulation efﬁciency of ClAlPc in Ogg particles was
associated with the good solubility of this photosensitizer in the
soybean oil. ClAlPc loading was affected by stabilizing and gelling
agent concentrations. There was a progressive increase in ClAlPc
loading with increasing PEI concentration, and a maximum was
reached for F3 and F4 formulations. On the other hand, for HSA
concentration the F3 formulation prepared with 6% (w/w) showed
higher loading rate (60.3%) than F6 and F7 formulations. These
ﬁndings could be attributed to better electrostatic interaction be-
tween PEI and HSA at concentrations 0.30% and 6%, respectively,
which culminated in excellent stabilization of the ClAlPc Ogg par-
ticles and limited coating of the glass surface with these particles
[7,18].
Colloidal particles dispersion stability can be controlled by the
electric layer present on the dispersed phase, which generates
electrostatic repulsion among the particles. F3 and F4 formulations
showed excellent stability over six months of storage. This stability
resulted from a protective corona of PEI on the particle surface
leading to electrostatic and steric stabilization. On the other hand,
F1 formulation was unstable after ﬁrst month. These results agree
with those obtained by Kirilov et al. [18] which demonstrated that
gelled particles prepared with low stabilizing agent concentration
were unstable after 45 days. Therefore, the colloidal ClAlPc Ogg
particle dispersion prepared with 0.30% PEI (w/v), 6% HSA (w/w),
and 5% soybean oil (w/v) (F3 formulation) showed the most appro-
priate characteristics for a drug delivery system: small particle
size, homogeneous size distribution, and a large zeta potential.
The thermal behavior of Ogg and ClAlPc Ogg was studied by
DSC. Heating prompted endothermic transitions corresponding to
melting of the gel. Both the melting temperature and enthalpy in-
creased with rising HSA concentration. The results from thermal
analyses also showed that ClAlPc did not affect the melting process
of Ogg or ClAlPc Ogg. However, the gelation properties changed in
the case of ClAlPc Ogg. The sol–gel transition is complex and, for
the low-molecular-weight gelling agent HSA, this process is based
on molecular self-assembly via non-covalent interactions (hydro-
phobic interactions, van der Waals, and hydrogen bonding). In gen-
eral, the HSA ﬁbrous network is formed in three stages: primary
nucleation of the gelator molecules, growth of the ﬁbers, and sub-
sequent branching formed by the three-dimensional network. HSA
ﬁber formation starts when the solution is cooled below the gela-
tion temperature and the solution becomes supersaturated [31,32].
Accordingly, the ClAlPc inﬂuence on the gelation process may be
due to strong hydrophobic interactions between the photosensi-
tizer and lipophilic carbon chain of HSA slightly altering the forma-
tion of the ﬁbrous network.5. Conclusion
We have successfully encapsulated a hydrophobic chloroalumi-
num phthalocyanine (ClAlPc) sensitizer into gelled particles of soy-
bean oil. The ClAlPc Ogg particles were prepared by hot
emulsiﬁcation in water and cooling, and they were efﬁciently sta-
bilized as a colloidal dispersion by polyethyleneimine (PEI). The
amount of PEI and 12-hydroxystearic acid (HSA) used in the for-
mulations affected particle size and colloidal dispersion stability.
The phthalocyanine interacted weakly with the gelation process,
leading to good encapsulation and potential use of the resulting
ClAlPc Ogg particles in photodynamic therapy protocols.Acknowledgments
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